Investors & Media
Dicerna to Participate in Upcoming Investor Conferences
H.C. Wainwright20th Annual Global Investment Conference, Wednesday, September 5, 2018at 1:45 p.m. ET, at The St. Regis in New York. Dr. Fambrough will present a corporate update and overview of the Company’s most advanced GalXC™ pipeline programs, including DCR-PHXC, an investigational RNAi therapeutic in development for the treatment of all forms of primary hyperoxaluria. A live webcast of the presentation can be accessed on the Investors & Media section on the Dicerna website at www.dicerna.com. An archived replay of the webcast will be available on the Company’s website after the conference.
Citi’s 13th Annual
Biotech Conference, Thursday, September 6, 2018, in Boston. Dr. Fambrough will be available for one-on-one meetings with investors at the conference.